Novartis AG
NOVNN MF
NOVNN MFNovartis AG
MEXICO1,719.29
MXN
-35.31
(-2.01%)
Company Description
- Full Time Employees
- 76,057
- Sector
- Healthcare
- Industry
- Drug Manufacturers—General
- Address
- Lichtstrasse 35 Basel Switzerland 4056
- IPO Date
- Apr 3, 1995
- Website
- www.novartis.com
- Business
- Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. It offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.